New Concepts in the Management of Retinal Vein Occlusions

Sabia, H; Agarwal, Aniruddha; Ram, Jagat

doi:10.15406/aovs.2017.06.00203

Cited by 2 publications

(8 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Keduanya memiliki bentuk iskemik dan non iskemik. 2 BRVO atau sumbatan cabang pembuluh darah vena retina lebih sering sering terjadi. Penelitian Beaver Dam melaporkan insidensi kumulatif RVO selama 15 tahun sebanyak 2,3% populasi, dengan mayoritasnya (78%) adalah BRVO.…”

Section: Pendahuluanunclassified

“…Faktor resiko lain termasuk diabetes melitus, merokok dan hiperlipidemia. 1,2,5,6 Pada BRVO dapat terjadi penurunan tajam penglihatan yang disebabkan oleh munculnya edema makula, iskemik makula atau neovaskularisasi sekuele. 2,4,6 Tujuan utama penatalaksanaan BRVO adalah mempertahankan tajam penglihatan yang masih baik agar tidak menurun secara progresif dan mencegah timbulnya komplikasi.…”

Section: Pendahuluanunclassified

“…1,2,5,6 Pada BRVO dapat terjadi penurunan tajam penglihatan yang disebabkan oleh munculnya edema makula, iskemik makula atau neovaskularisasi sekuele. 2,4,6 Tujuan utama penatalaksanaan BRVO adalah mempertahankan tajam penglihatan yang masih baik agar tidak menurun secara progresif dan mencegah timbulnya komplikasi. The collaborative Branch Vein Occlusion Study (BVOS) memperlihatkan bahwa tindakan laser fotokoagulasi disertai pemberian antivascular endothelial growth factor (VEGF), seperti bevacizumab efektif dalam meningkatkan ketajaman penglihatan dan menurunkan edema makula.…”

Section: Pendahuluanunclassified

“…The collaborative Branch Vein Occlusion Study (BVOS) memperlihatkan bahwa tindakan laser fotokoagulasi disertai pemberian antivascular endothelial growth factor (VEGF), seperti bevacizumab efektif dalam meningkatkan ketajaman penglihatan dan menurunkan edema makula. 2,4,6…”

Section: Pendahuluanunclassified

“…Keadaan tersebut memicu akumulasi pada makula. 2,10,13 Optical coherence tomography (OCT) merupakan modalitas pencitraan yang paling penting dalam pengobatan pasien dengan BRVO dan edema makula. OCT dapat digunakan untuk memantau keberhasilan pengobatan pada edema makula.…”

Section: 10unclassified

See 4 more Smart Citations

Injeksi Intravitreal Bevacizumab Dan Laser Fotokoagulasi Pada Branch Retinal Vein Occlucion

Laidasuri

2021

Human Care

View full text Add to dashboard Cite

Introduction: Branch retinal vein occlusion (BRVO), occurs at a retinal arteriovenous intersection, is a common cause of retinal vascular disease. The risk factors such as hypertension, arteriosclerosis, diabetes, smoking, hyperlipidemia, and glaucoma. BRVO affects males and females equally and occurs most frequently between the ages of 50 and 70. Vision loss from BRVO is typically due to macular ischemia, macular edema, or complications from neovascular disease Method: Reported a case of BRVO in a man, 50years-old with 10 years hypertension history, came to M.Djamil Hospital) with decreased vision of right eye since one month ago. Visual acuity right eye was 6/18 and visual acuity left eye was 6/6. aa:vv was 1:3,av crossing and venous tortuosity in superotemporal quadran. There was flame shape hemorrages and cotton-wool spot in same area. Foveal reflex was decreased. Central macular thickness was 466 µm on OCT. The management was injection bevacizumab intravitreal and then argon laser photocoagulation 3 weeks later. Result: After 3weeks, macular edema is decreased (234µm) and visual acuity improve up to +3lines of snellen chart (6/6). Conclusion: Combination of bevacizumab intravitreal injection as anti VEGF and laser photocoagulation on leakage area was effective in reducing of macular edema and visual acuity improvement.

show abstract

Section: Pendahuluanunclassified

Section: 10unclassified

See 3 more Smart Citations

Injeksi Intravitreal Bevacizumab Dan Laser Fotokoagulasi Pada Branch Retinal Vein Occlucion

Laidasuri

2021

Human Care

View full text Add to dashboard Cite

show abstract

Comparing the Optical Coherence Tomography Outcomes of Intravitreal Injection Anti Vascular Endothelial Growth Factor in Branch Retinal Vein Occlusion (BRVO)

Sandri,

Weni Helvinda

2023

Bioscmed

View full text Add to dashboard Cite

Background: BRVO is a blockage of the branches of the retinal vein due to a thrombus. The prevalence of 10-year BRVO is 1.6 per 100 subjects. The effect of anti-VEGF injection on BRVO management is effective in improving visual acuity and reducing macular oedema. Case presentation: A man, 32 years old, presented to the ophthalmology clinic at the Dr. M. Djamil General Hospital with a chief complaint of blurred vision in his left eye 1 week before admission. The blurred vision began suddenly. Visual acuity in LE was 20/50 and did not advance with a pinhole. Funduscopic examination of LE showed clear media, rounded papillae with well-defined borders, blood vessels aa:vv = 1:3, venous tortuosity (+) increased in the inferotemporal quadrant; retina: Bleeding (+) with dot blot and flame-shaped inferiorly, exudate (+) cotton wool spots at the inferotemporal region; foveal reflex (+)↓ on the macula. OCT LE examination showed macular intraretinal hypo-reflection and macular thickening with a central macular thickness of 617 μm. The physical examination showed a body weight of 114.9 kg, a height of 173 cm, and a body mass index of 38.4. Within 5 months after 3 times administrations of intravitreal injections of anti-VEGF bevacizumab and ranibizumab, visual acuity of LE: 20/25 was obtained, and increased appearance of the retinal fundus and OCT LE. Conclusion: Intravitreal injection therapy of anti-VEGF bevacizumab and ranibizumab is effective in reducing macular oedema and restoring visual acuity in BRVO.

show abstract

New Concepts in the Management of Retinal Vein Occlusions

Cited by 2 publications

References 8 publications

Injeksi Intravitreal Bevacizumab Dan Laser Fotokoagulasi Pada Branch Retinal Vein Occlucion

Injeksi Intravitreal Bevacizumab Dan Laser Fotokoagulasi Pada Branch Retinal Vein Occlucion

Comparing the Optical Coherence Tomography Outcomes of Intravitreal Injection Anti Vascular Endothelial Growth Factor in Branch Retinal Vein Occlusion (BRVO)

Contact Info

Product

Resources

About